RedHill [NASDAQ: RDHL] Announces Partnership With Cosmo Pharma
RedHill Biopharma Ltd. [NASDAQ: RDHL] disclosed Thursday it has partnered with Cosmo Pharmaceuticals. Both the companies entered into an agreement…
Novavax [NASDAQ: NVAX] And Takeda [NYSE: TAK] Teams Up For COVID-19 Vaccine In Japan
Novavax, Inc. [NASDAQ: NVAX] and Takeda Pharmaceutical Company Limited [NYSE: TAK] both teamed up to develop, commercialize Novavax’s COVID-19 candidate…
Teladoc Health [NYSE: TDOC] Announces Merger With Livongo Health [NASDAQ: LVGO]
Telehealth market leader Teladoc Health, Inc. [NYSE: TDOC] disclosed Wednesday it would buy Livongo Health, Inc. [NASDAQ: LVGO]. Both companies…
Edgewell [NYSE: EPC] Decides To Buy CREMO Company For $235 Million
Edgewell Personal Care Company [NYSE: EPC] disclosed Tuesday its plan to acquire a premier men’s grooming company in the US,…
Elanco [NYSE: ELAN] Finalizes Acquisition Of Bayer Animal Health
Elanco Animal Health Incorporated [NYSE: ELAN] disclosed Monday it has completed the Acquisition of Bayer Animal Health. The $6.89 billion…
Bilibili [NASDAQ: BILI] Strikes Deal With Riot Games For Live Broadcasting License
Bilibili Inc. [NASDAQ: BILI] announced Monday it has entered into a strategic partnership with Riot Games. Bilibili aimed for a…
Gencor Inc. [NASDAQ: GENC] Plans To Buy Blaw-Knox Business From Volvo CE
Gencor Industries, Inc. [NASDAQ: GENC], a construction machinery manufacturing company disclosed Friday it has entered into an agreement with Volvo…
Axovant [NASDAQ: AXGT] Inks AXO-LENTI-PD Supply Deal With Oxford Biomedica
Axovant Gene Therapies Ltd. [NASDAQ: AXGT] disclosed today that its subsidiary has inked a three-year Clinical Supply Agreement (CSA) with…
Moderna Inc.’s [NASDAQ: MRNA] Board Member Dr. Nabel Resigns
Moderna Inc.[NASDAQ: MRNA], a clinical-stage biotechnology company disclosed that Dr. Nabel Elizabeth from the board of directors resigned. She is…
AstraZeneca [NYSE: AZN] And Sanofi’s [NASDAQ: SNY] Nirsevimab Shows Positive Result In Phase 2 Trial
AstraZeneca PLC [NYSE: AZN] and development partner Sanofi’s [NASDAQ: SNY] nirsevimab has shown a promising result in Phase 2 clinical…
